AFL.NYSEAflac INC

Form 4: Director Joseph L. Moskowitz Acquires Aflac Shares

Sentiment:

Statement of Changes in Beneficial Ownership


Aflac Incorporated Director Joseph L. Moskowitz acquired 1,721 shares of common stock through an equity incentive plan.

Summary

  • Director Joseph L. Moskowitz received a grant of 1,721 shares of Aflac Incorporated common stock.
  • The transaction occurred on May 4, 2026.
  • The shares were granted under the Aflac Incorporated Long-Term Incentive Plan.
  • Following this transaction, the director's total beneficial ownership is 25,968 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

  • Increased equity alignment between the director and shareholders.

Negatives

  • None identified.

Risks

  • None identified.

Future Outlook

Not applicable as this is a routine disclosure of director equity compensation.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to align leadership interests with long-term shareholder value in the insurance sector.

Comparison to Industry Standards

  • The grant is consistent with standard executive and director compensation packages for large-cap financial services firms.

Stakeholder Impact

  • Positive alignment of director interests with shareholder outcomes.

Next Steps

  • None identified.

Key Dates

DateDescription
05/04/2026Date of the equity grant transaction.
05/06/2026Date the Form 4 was signed and filed.

Keywords

Aflac, AFL, Insider Trading, Form 4, Director Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.